VENTOLIN
LOE ApproachingNDAINHALATIONAEROSOL, METEREDPriority Review
Approved
May 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4
Data completeness
2/8 — Basic
Priority Review
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VENTOLIN is albuterol (salbutamol), a selective beta-2 adrenergic agonist delivered via metered-dose inhaler for acute bronchospasm relief in asthma. It works by activating beta-2 receptors on airway smooth muscle, increasing intracellular cyclic AMP and causing rapid bronchodilation. The drug provides onset of improvement within 5 minutes and remains a foundational rescue therapy in asthma management.
LOE Approaching
Legacy product in LOE-approaching phase with declining growth; career focus likely shifting to defending market share and managing transition to next-generation therapies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (4)
A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma
Started Feb 2025
118 enrolled
Asthma
Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants
Started Apr 2023
28 enrolled
Asthma
A Study to Assess the Systemic Exposure of FLIXOTIDE™ (Fluticasone Propionate) and SERETIDE™ (Fluticasone Propionate and Salmeterol) Given With VENTOLIN™ Mini-Spacer Compared to the Aerochamber Plus Spacer
Started Jan 2014
21 enrolled
Asthma
A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler® and Ventolin® MDI in Stable Asthma Patients
Started Mar 2009
17 enrolled
Asthma
Worked on VENTOLIN at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.